BASEL, Switzerland I July 25, 2025 I Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the ...

Get the latest biopharma news, clinical trial updates, and industry insights at PipelineReview.com. Discover innovative therapies and regulatory news.

PARIS, France I July 25, 2025 I Following the positive opinion by the European Medicines Agency's Committee for Medicinal Products for Human Use on June 19, ...

LONDON, UK I July 24, 2025 I GSK plc (LSE/NYSE: GSK) today announced the approval of Blenrep in the European Union (EU) for the treatment of adults with ...

PARIS, France I July 24, 2025 I Ipsen announced today that the European Commission has approved Cabometyx® (cabozantinib) for adult patients with unresectable ...

SCHLIEREN / ZURICH, Switzerland I July 25, 2025 I Memo Therapeutics AG ("MTx”), a late-stage biotech company translating unique immune responses into superior ...

BRUSSELS, Belgium I July 24, 2025 I Precirix, a clinical-stage biopharmaceutical company focused on developing innovative targeted radiopharmaceutical ...

GAITHERSBURG, MD, USA I July 24, 2025 I Novavax, Inc. (Nasdaq: NVAX) today announced preclinical data demonstrating that Novavax's H5N1 avian pandemic ...

NEW YORK, NY, USA I July 24, 2025 I GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, today announced its IND ...

Restructuring pipeline to focus on AAV cardiovascular platform (Danon disease, PKP2-ACM, BAG3-DCM) and regulatory activities for KRESLADI™ (severe LAD-I), ...

CAMBRIDGE, MA, USA I July 23, 2025 I Apnimed, Inc., a pharmaceutical company advancing an industry-leading pipeline of first-in-class oral therapies that ...

Landmark approval is based on results from the Phase 3 AQUILA study, showing fixed-duration treatment with daratumumab significantly reduced the risk of ...